2 unknown, 1 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Not yet recruiting 1 |
Follow pirarubicin: new trials by email Literature Review of pirarubicin trials Research Report on pirarubicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Therapy of Anthracyclines for Children With Nephroblastoma Vincristine, Oxytetracycline/ Cyclophosphamide, Liposomal doxorubicin - 0.5-14 Year Old Children With Nephroblastoma | Phase 4 | Not yet recruiting | Shengjing Hospital | 120 | 2019-06-01 | 2019-03-27 |
| Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer Doxorubicin Hydrochloride Liposome injection and cyclophosphamide, pirarubicin and cyclophosphamide - Breast Cancer | Phase 4 | Unknown | Hebei Medical University Fourth Hospital | 300 | 2016-09-01 | 2016-09-16 |
| CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Cyclophosphamide 750mg/m2, Vincristine 1.4mg/m2, Doxorubicin 50mg/m2 - ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified | Phase 4 | Unknown | Ruijin Hospital | 200 | 2012-09-01 | 2017-11-14 |
Breast Neoplasms (1) · Enteropathy-Associated T-Cell Lymphoma (1) · Immunoblastic Lymphadenopathy (1) · Subcutaneous panniculitis-like T-cell lymphoma (1) · Wilms Tumor (1)
Hebei Medical University Fourth Hospital (1) · Ruijin Hospital (1) · Shengjing Hospital (1)
China (3)